secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2022-07-26T23:59:59+00:00
Accession:  0001157523-22-000903
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q2 net sales $264M (-21% YoY), EPS $1.00 (-47%); FY2022 outlook reiterated
--------------------------------------------------------------------------------

- Net sales $264M (-21% YoY, -18% constant currency); diluted EPS $1.00 vs $1.87 prior year.
- Active customers 559K (-14% YoY); Greater China active customers 278K (-8% YoY, +9% sequentially).
- FY2022 guidance maintained: net sales $1.015B-$1.065B, diluted EPS $3.85-$4.45.
- No share repurchases during quarter; cash $230M; $83M remaining under buyback authorization.
- COVID disruptions in mainland China and other key markets drove underperformance; inflationary pressures noted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752322000903/0001157523-22-000903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752322000903/a52792490.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-000903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer